Results 31 to 40 of about 774,961 (340)

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration’s Adverse Event Reporting System

Saudi Pharmaceutical Journal, 2023
Objectives: This study was designed to assess the disproportionality analyses of adverse drug reactions (ADRs) related to hydroxychloroquine and remdesivir and how ADR reporting fluctuated during the COVID-19 pandemic.
Deemah S. Alsuhaibani, Heba H. Edrees, Thamir M Alshammari   +2 more
doaj   +1 more source

Association of medication storage with diabetes control: A cross-sectional study from Saudi Arabia

Saudi Pharmaceutical Journal, 2020
Background: In addition to diet restriction and physical activity, diabetes mellitus is managed by the chronic use of medications that require appropriate storage conditions to maintain their stability and effectiveness.
Ali F. Altebainawi, Mubarak N. Alrashidi, Moaath K. Aljbreen, Muhammad Majid Aziz, Abdullah A. Alhifany, Mohamad Aljofan, Thamir M. Alshammari   +6 more
doaj   +1 more source

Oral diabetes medication monotherapy and short-term mortality in individuals with type 2 diabetes and coronary artery disease [PDF]

, 2018
Objective To determine whether sulfonylurea use, compared with non-sulfonylurea oral diabetes medication use, was associated with 2-year mortality in individuals with well-controlled diabetes and coronary artery disease (CAD). Research design and methods
Berkowitz, Seth A, Caplan, Liron, Grunwald, Gary K, Liu, Wenhui G, Maddox, Thomas M, Raghavan, Sridharan, Reusch, Jane E.B, Saxon, David R   +7 more
core   +3 more sources

Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example

Saudi Pharmaceutical Journal, 2020
Late in 2019, several cases of infection with a new strain of coronavirus were reported in China. This new strain was later officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO).
Thamir M. Alshammari, Ali F. Altebainawi, Khalidah A. Alenzi   +2 more
doaj   +1 more source

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine. [PDF]

, 2017
BackgroundDFN-02 is a novel intranasal spray formulation composed of sumatriptan 10 mg and a permeation-enhancing excipient comprised of 0.2% 1-O-n-Dodecyl-β-D-Maltopyranoside (DDM).
Allenby, Kent, Brand-Schieber, Elimor, Cady, Roger K, Munjal, Sagar, Rapoport, Alan M, Spierings, Egilius LH   +5 more
core   +1 more source

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale, Alessandro Crocoli, Giuseppe Maria Milano, Pierluigi Di Paolo, Francesca Diomedi Camassei, Ida Russo, Annalisa Serra   +6 more
wiley   +1 more source

Weight management medications for chronic use in 37 veterans affairs medical centers—A medication use evaluation

Obesity Science & Practice
Rationale Controlled trials have demonstrated successful weight loss associated with certain weight management medications (WMMs). However, there are limited real‐world data on prescribing patterns and efficacy and safety profiles of WMMs in Veterans ...
Samantha Walczuk, Muriel Burk, Elaine Furmaga, Samaneh Ghassemi, Madeline McCarren, Kenneth Bukowski, Peter Glassman, Fran Cunningham   +7 more
doaj   +1 more source

Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide

Saudi Pharmaceutical Journal, 2021
Background: The coronavirus disease 2019 (COVID-19) pandemic has affected many countries negatively, particularly in terms of their health care and financial systems. Numerous countries have attempted to employ precautions to address this pandemic.
Thamir M. Alshammari, Khalidah A. Alenzi, Fatemah A. Alnofal, Ghada Fradees, Ali F. Altebainawi   +4 more
doaj   +1 more source

Psychosocial Outcomes in Patients With Endocrine Tumor Syndromes: A Systematic Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The combination of disease manifestations, the familial burden, and varying penetrance of endocrine tumor syndromes (ETSs) is unique. This review aimed to portray and summarize available data on psychosocial outcomes in patients with ETSs and explore gaps and opportunities for future research and care.
Daniël Zwerus, Floortje Strobbe, Annemarie A. Verrijn Stuart, Hanneke M. van Santen, Gerlof D. Valk, Sasja A. Schepers, Rachel S. van Leeuwaarde   +6 more
wiley   +1 more source

The impact of implementing a hospital electronic prescribing and administration system on clinical pharmacists’ activities - a mixed methods study

BMC Health Services Research, 2019
Background The increasing adoption of hospital electronic prescribing and medication administration (ePA) systems has driven a wealth of research around the impact on patient safety.
Monsey McLeod, Georgios Dimitrios Karampatakis, Lore Heyligen, Ann McGinley, Bryony Dean Franklin   +4 more
doaj   +1 more source